Xue YT - Search Results

1

A Liquid-Liquid Phase Separation-Related Index Associate with Biochemical Recurrence and Tumor Immune Environment of Prostate Cancer Patients.

You Q, Chen JY, Wu XH, Xue YT, Sun JB, Wei Y, Zheng QS, Xue XY, Chen DN, Xu N. You Q, et al. Among authors: xue yt, xue xy. Int J Mol Sci. 2023 Mar 14;24(6):5515. doi: 10.3390/ijms24065515. Int J Mol Sci. 2023. PMID: 36982591 Free PMC article.

2

A radiation resistance related index for biochemical recurrence and tumor immune environment in prostate cancer patients.

Ke ZB, You Q, Chen JY, Sun JB, Xue YT, Zhuang RB, Zheng QS, Chen YH, Wei Y, Sun XL, Xue XY, Xu N. Ke ZB, et al. Among authors: xue yt, xue xy. Comput Biol Med. 2022 Jul;146:105711. doi: 10.1016/j.compbiomed.2022.105711. Epub 2022 Jun 7. Comput Biol Med. 2022. PMID: 35701253

3

Low TLR and PSMA-TV predict biochemical response to abiraterone acetate in metastatic prostate cancer patients developing castration resistance after chemohormonal therapy at hormone-sensitive stage.

Ke ZB, Chen JY, You Q, Sun JB, Xue YT, Ye XJ, Chen SH, Xue XY, Sun XL, Chen DN, Wei Y, Zheng QS, Chen SM, Xu N. Ke ZB, et al. Among authors: xue yt, xue xy. J Cancer Res Clin Oncol. 2023 Jul;149(8):5071-5084. doi: 10.1007/s00432-022-04438-8. Epub 2022 Nov 4. J Cancer Res Clin Oncol. 2023. PMID: 36333565

4

Head-to-head comparisons of [⁶⁸Ga]Ga-PSMA-11 PET/CT, multiparametric MRI, and prostate-specific antigen for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high-risk non-metastatic prostate cancer patients: a prospective study.

Ke ZB, Chen SM, Chen JY, Chen SH, You Q, Sun JB, Xue YT, Sun XL, Wu XH, Zheng QS, Wei Y, Xue XY, Xu N. Ke ZB, et al. Among authors: xue yt, xue xy. Eur J Nucl Med Mol Imaging. 2023 Mar;50(4):1240-1251. doi: 10.1007/s00259-022-06047-6. Epub 2022 Nov 22. Eur J Nucl Med Mol Imaging. 2023. PMID: 36416906

5

Body composition parameters were associated with response to abiraterone acetate and prognosis in patients with metastatic castration-resistant prostate cancer.

Ke ZB, You Q, Xue YT, Sun JB, Chen JY, Liu WQ, Wei Y, Zheng QS, Li XD, Xue XY, Xu N. Ke ZB, et al. Among authors: xue yt, xue xy. Cancer Med. 2023 Apr;12(7):8251-8266. doi: 10.1002/cam4.5640. Epub 2023 Feb 7. Cancer Med. 2023. PMID: 36750989 Free PMC article.

6

A tumor-associated macrophages related model for predicting biochemical recurrence and tumor immune environment in prostate cancer.

Chen JY, Huang XY, Lin F, You Q, Xue YT, Lin B, Zheng QS, Wei Y, Xue XY, Li XD, Chen DN, Xu N. Chen JY, et al. Among authors: xue yt, xue xy. Genomics. 2023 Sep;115(5):110691. doi: 10.1016/j.ygeno.2023.110691. Epub 2023 Jul 27. Genomics. 2023. PMID: 37516327 Free article.

7

A novel CD8⁺ T cell-related gene signature for predicting the prognosis and immunotherapy efficacy in bladder cancer.

Lin F, Ke ZB, Xue YT, Chen JY, Cai H, Lin YZ, Li XD, Wei Y, Xue XY, Xu N. Lin F, et al. Among authors: xue yt, xue xy. Inflamm Res. 2023 Aug;72(8):1665-1687. doi: 10.1007/s00011-023-01772-6. Epub 2023 Aug 14. Inflamm Res. 2023. PMID: 37578544

8

Prospective analysis of the diagnostic accuracy of digital rectal examination and magnetic resonance imaging for T staging of prostate cancer.

Zhu J, Wu X, Xue Y, Li X, Zheng Q, Xue X, Huang Z, Chen S. Zhu J, et al. J Cancer Res Ther. 2023 Aug;19(4):1024-1030. doi: 10.4103/jcrt.jcrt_176_23. J Cancer Res Ther. 2023. PMID: 37675732 Free article.

9

Ubiquitin-specific protease 5 promotes bladder cancer progression through stabilizing Twist1.

Cai H, Ke ZB, Chen JY, Li XD, Zhu JM, Xue YT, Ruan ZT, Wang Z, Lin F, Zheng QS, Wei Y, Xue XY, Xu N. Cai H, et al. Among authors: xue yt. Oncogene. 2024 Mar;43(10):703-713. doi: 10.1038/s41388-023-02936-8. Epub 2024 Jan 13. Oncogene. 2024. PMID: 38218898

10

A computed tomography-based comprehensive standardized adrenal tumor scoring model for predicting the perioperative outcomes of retroperitoneal laparoscopic adrenal surgery.

Xue YT, Chen JY, Yan XL, Lin F, Chen DN, Zheng JJ, Chen YH, Xue XY, Wei Y, Zheng QS, Li XD, Xu N. Xue YT, et al. Quant Imaging Med Surg. 2024 Jan 3;14(1):489-502. doi: 10.21037/qims-23-764. Epub 2024 Jan 2. Quant Imaging Med Surg. 2024. PMID: 38223067 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters